- The Wall Street Journal•21 days ago
Pfizer Inc. has agreed to buy the assets of Bind Therapeutics Inc., a biotechnology company working on developing cancer treatments, out of bankruptcy for $20 million subject to higher bids at auction....
- Capital Cube•2 months ago
Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to BIND Therapeutics, Inc.Here are 5 ETF’s with the largest exposure to BIND-US. Comparing the performance and risk of BIND Therapeutics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us […] (Read more...) The post ETF’s with exposure to BIND Therapeutics, Inc. : May 19, 2016 appeared first on CapitalCube.
BIND Therapeutics, Inc.NasdaqGS
After hours: 1.200.27 (29.03%) as of 7:59 PM EDT
|Bid||1.05 x 100|
|Ask||1.19 x 1000|
|52wk Range||0.35 - 5.25|
|Day's Range||0.62 - 1.00|
|Avg Vol (3m)||855,447|
As of 4:00 PM EDT. Market closed.